Source: Circulation. Conference titles: American Heart Associations of the Scientific Sessions and Resuscitation Science Symposium. Unidade: FM
Subjects: MEDICAMENTO, ANTICOAGULANTES, SÍNDROME CORONARIANA AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
O'DONOGHUE, Michelle L. et al. The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A11382?sid=6b0e288c-1566-44fe-b492-e72d89bd73f4. Acesso em: 16 nov. 2024. , 2013APA
O'Donoghue, M. L., Mega, J. L., Braunwald, E., Nicolau, J. C., Bhatt, D. L., Murphy, S. A., & Gibson, C. M. (2013). The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A11382?sid=6b0e288c-1566-44fe-b492-e72d89bd73f4NLM
O'Donoghue ML, Mega JL, Braunwald E, Nicolau JC, Bhatt DL, Murphy SA, Gibson CM. The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial [Internet]. Circulation. 2013 ; 128( 22):[citado 2024 nov. 16 ] Available from: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A11382?sid=6b0e288c-1566-44fe-b492-e72d89bd73f4Vancouver
O'Donoghue ML, Mega JL, Braunwald E, Nicolau JC, Bhatt DL, Murphy SA, Gibson CM. The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial [Internet]. Circulation. 2013 ; 128( 22):[citado 2024 nov. 16 ] Available from: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A11382?sid=6b0e288c-1566-44fe-b492-e72d89bd73f4
